Electra Therapeutics, Inc. (ETRA) stock
ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.43+0.08 (+0.96%)
Close on Nov 18, 2026Market cap $529.97MP/E –Yield –
Electra Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$25.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.02M | – |
See a number that looks wrong?